NEW YORK, May 1, 2015 /PRNewswire/ --
Moments ago, Analysts Review released new research updates concerning several important developing situations including Huntington Bancshares Incorporated (NASDAQ: HBAN), Wells Fargo & Company (NYSE: WFC), JPMorgan Chase & Co (NYSE: JPM), Regions Financial Corporation (NYSE: RF), and Pfizer, Inc. (NYSE: PFE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
HBAN Research Report: ( http://get.analystsreview.com/pdf/?c=Huntington%20Bancshares&d=01-May-2015&s=HBAN ),
WFC Research Report: ( http://get.analystsreview.com/pdf/?c=Wells%20Fargo&d=01-May-2015&s=WFC ),
JPM Research Report: ( http://get.analystsreview.com/pdf/?c=JPMorgan%20Chase&d=01-May-2015&s=JPM ),
RF Research Report: ( http://get.analystsreview.com/pdf/?c=Regions%20Financial&d=01-May-2015&s=RF ),
PFE Research Report: ( http://get.analystsreview.com/pdf/?c=Pfizer&d=01-May-2015&s=PFE ).
============
--
Analyst Update: Acquisition, Launch of Business Unit, New Investment, Dividend, and Earnings
Reviewed by: Rohit Tuli, CFA®
U.S. stocks tumbled on Thursday as Fed remained apprehensive about the interest rate outlook amid weaker than expected US first quarter economic data. The NASDAQ Composite was down 1.64%, to finish at 4941.42; the Dow Jones Industrial Average slipped 1.08%, to 17,840.52, and the S&P 500 ended 1.01% lower, at 2,085.51. Most importantly, the NASDAQ biotech index dropped 3.05% on Thursday and was down 8.1% in the past one week, led by disappointing earnings. European stocks gained on Thursday, supported by the strong euro and news of euro bloc's recovery from four consecutive months of deflation. Germany's DAX 30 rose 0.19%; France's CAC 40 jumped 0.14%, and the London's FTSE 100 closed 0.21% higher. Meanwhile, Asian markets mostly disappointed on Thursday. Japan's Nikkei, Australia's S&P ASX and Hong Kong's Hang Seng index all fell on Thursday.
On April 1, 2015, Huntington Bancshares Inc. announced the completion of its acquisition of Michigan-based Macquarie Equipment Finance, Inc. from its parent company, Sydney-based Macquarie Group Ltd (MEF-US).
On April 21, 2015, Wells Fargo & Company announced that it has created a specialty business group, Senior Housing Finance, to provide traditional banking and credit services for senior housing developers, investors, and operators.
On March 16, 2015, JPMorgan Chase and Omidyar Network announced a $10 million combined investment in FIRST, a private equity fund focused on serving the needs of low-income and underserved populations in Brazil.
On April 23, 2015, the Board of Directors of Regions Financial Corporation declared a quarterly cash dividend of $0.06 per common share and authorized an equity repurchase program for up to $875 million of the Company's common stock.
On April 28, 2015, Reuetrs reported that Pfizer Inc. saw a 4% fall in Q1 FY15 revenue to $10.86 billion, hurt by a stronger dollar, but was above analysts' estimate of $10.76 billion. However, the drugmaker reported a better-than-expected profit, helped by demand for its vaccines and cancer drugs.
--
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
